Amide-I and -II Vibrations of the Cyclic β-Sheet Model Peptide Gramicidin S in the Gas Phase

被引:60
|
作者
Kupser, Peter [1 ]
Pagel, Kevin [2 ]
Oomens, Jos [3 ]
Polfer, Nick [3 ]
Koksch, Beate [2 ]
Meijer, Gerard [1 ]
von Helden, Gert [1 ]
机构
[1] Max Planck Gesell, Fritz Haber Inst, D-14195 Berlin, Germany
[2] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany
[3] EURATOM, FOM, Inst Plasmaphys, NL-3439 MN Nieuwegein, Netherlands
关键词
ORNITHINE SIDE-CHAINS; MIDINFRARED SPECTROSCOPY; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; AMINO-ACID; STEREOCHEMISTRY; DERIVATIVES; SECONDARY; SYSTEMS;
D O I
10.1021/ja909842j
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In the condensed phase, the peptide gramicidin S is often considered as a model system for a beta-sheet structure Here, we investigate gramicidin S free of any influences of the environment by measuring the mid-IR spectra of doubly protonated (deuterated) gramicidin S in the gas phase In the amide I (i e, C=O stretch) region, the spectra show a broad split peak between 1580 and 1720 cm(-1). To deduce structural information, the conformational space has been searched using molecular dynamics methods and several structural candidates have been further investigated at the density functional level The calculations show the importance of the interactions of the charged side-chains with the backbone, which is responsible for the lower frequency part of the amide I peak When this interaction is inhibited via complexation with two 18-crown-6 molecules, the amide I peak narrows and shows two maxima at 1653 and 1680 cm(-1) A comparison to calculations shows that for this complexed ion, four C=O groups are in an antiparallel beta-sheet arrangement Surprisingly, an analysis of the calculated spectra shows that these beta-sheet C=O groups give rise to the vibrations near 1680 cm(-1) This is in sharp contrast to expectations based on values for the condensed phase, where resonances of beta-sheet sections are thought to occur near 1630 cm(-1) The difference between those values might be caused by interactions with the environment, as the condensed phase value is mostly deduced for beta-sheet sections that are embedded in larger proteins, that interact strongly with solvent or that are part of partially aggregated species
引用
收藏
页码:2085 / 2093
页数:9
相关论文
共 24 条
  • [21] Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer
    Masuzawa, Toru
    Fujiwara, Yoshiyuki
    Okada, Kaoru
    Nakamura, Ayumu
    Takiguchi, Shuji
    Nakajima, Kiyokazu
    Miyata, Hiroshi
    Yamasaki, Makoto
    Kurokawa, Yukinori
    Osawa, Ryuji
    Takeda, Kazuyoshi
    Yoshida, Koji
    Tsunoda, Takuya
    Nakamura, Yusuke
    Mori, Masaki
    Doki, Yuichiro
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 41 (04) : 1297 - 1304
  • [22] Antibody Responses to Recombinant gp120, gp70 V1V2 Proteins and Cyclic V2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens
    Karasavvas, N.
    Karnasuta, C.
    de Souza, M. S.
    Madnote, S.
    Inthawong, D.
    Savadsuk, H.
    Rittiroongrad, S.
    Chantakulkij, S.
    Nitayaphan, S.
    Pitisuttithum, P.
    Thongcharoen, P.
    Siriyanon, V.
    Andrews, C. A.
    O'Connell, R. J.
    Michael, N. L.
    Ngauy, V.
    Kim, J. H.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (11) : A50 - A50
  • [23] Calculation of the microscopic and macroscopic linear and nonlinear optical properties of acetonitrile: I. Accurate molecular properties in the gas phase and susceptibilities of the liquid in Onsager's reaction-field model
    Reis, H
    Papadopoulos, MG
    Avramopoulos, A
    JOURNAL OF PHYSICAL CHEMISTRY A, 2003, 107 (19): : 3907 - 3917
  • [24] Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund's adjuvant (IFA) for resected high-risk melanoma
    Patel, Sapna P.
    Petroni, Gina R.
    Roszik, Jason
    Olson, Walter C.
    Wages, Nolan A.
    Chianese-Bullock, Kimberly A.
    Smolkin, Mark
    Varhegyi, Nikole
    Gaughan, Elizabeth
    Smith, Kelly T.
    Haden, Kathleen
    Hall, Emily H.
    Gnjatic, Sacha
    Hwu, Patrick
    Slingluff, Craig L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (08)